Project Title,Source,Relevant Links,Project Description
Californians Fighting Against COVID-19 Together (CA-Facts),Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/lorene-nelson 
https://profiles.stanford.edu/scott-boyd 
https://profiles.stanford.edu/jason-andrews 
https://med.stanford.edu/profiles/jason-andrews 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/julie-parsonnet 
https://profiles.stanford.edu/julie-parsonnet 
https://profiles.stanford.edu/lorene-nelson ","Parsonnet, Andrews, Boyd and Nelson are testing a random sample of 12,000 people in Solano and Santa Clara counties for COVID-19 antibodies. Subjects are mailed at-home test kits integrating a simple finger-stick blood test with smartphone-based applications that anonymously collect economic, clinical and demographic information and provide information back to the subject."
Validation of specimen self-collection vs. collection by health care worker for COVID-19 testing,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/yvonne-maldonado 
https://med.stanford.edu/profiles/prasanthi-govindarajan 
https://med.stanford.edu/profiles/andra-blomkalns 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/yvonne-maldonado ","Maldonado, Altamirano, Govindarajan and Blomkalns are investigating three swab techniques used during COVID-19 testing: a self-collected nasal swab performed with the aid of an instruction sheet; a health care worker-collected nasal swab; and a health care worker-collected oropharyngeal swab. Should self-collected nasal swabs prove as effective as those collected by health care workers, patients may be able to safely and effectively collect specimens outside of health care settings."
Lung function in people infected with SARS-CoV-2,Stanford," https://profiles.stanford.edu/carlos-milla?tab=research-and-scholarship 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== ","Milla and his team are evaluating whether improvements they’ve made in a lung function test can more successfully and safely identify subjects at high risk of severe COVID-19 disease, even when disease is in its early, asymptomatic stage. Standard tests involve inhaling deeply and quickly exhaling as much air as possible. The Milla lab’s improvements allow subjects to simply breathe passively for a few seconds through a mouthpiece. This not only makes the test feasible for sick subjects but also minimizes the generation of aerosols. "
Tracking COVID-19 with wearables,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/michael-snyder 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/60982 
https://med.stanford.edu/profiles/megan-mahoney ",Snyder and his team will track biological parameters of individuals who are ill with COVID-19 or at risk for the disease using a smart watch. Their goal is to determine whether they can tell if the smart watch user is becoming ill based on measurements such as heart rate.
Development and validation of molecular viability assays for SARS-CoV-2,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/yvonne-maldonado 
https://med.stanford.edu/profiles/jason-andrews 
https://profiles.stanford.edu/jason-andrews 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/yvonne-maldonado ","A key factor in the transmissibility of COVID-19 is a high level of virus shedding in the upper respiratory tract. Viral RNA can be detected for several weeks after the patient has recovered from disease and it is widely assumed that this genetic material is no longer infectious. The standard test for infection with SARS-CoV-2, RT-PCR, cannot discriminate between infectious and non-infectious SARS-CoV-2 RNA. Andrews, Maldonado and team are developing and validating an assay to distinguish between infectious virus from non-infectious shedding."
Repurposing snorkel masks for personal protective equipment,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://abslab.sites.stanford.edu/ 
https://med.stanford.edu/profiles/manu-prakash ","Prakash and his lab are repurposing full-face snorkel masks as reusable personal protective equipment for healthcare workers to help combat the shortage of personal protective equipment in hospitals. To ensure protection against airborne pathogens, the group is 3D-printing N95 filter attachments that are fitted to the snorkel masks. The prototypes are currently being tested in the three clinics currently."
Novel aerosol capture tools for understanding COVID-19 infectiousness,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/jason-andrews 
https://med.stanford.edu/profiles/jason-andrews 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== ","Andrews’ group is developing and validating tools to capture airborne biological particles and characterize infectiousness, with the goals of understanding predictors and determinants of infectiousness and potentially monitoring environments for presence of SARS-CoV-2."
Oral favipiravir compared to placebo in subjects with mild COVID-19,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/yvonne-maldonado 
https://med.stanford.edu/profiles/aruna-subramanian 
https://profiles.stanford.edu/marisa-holubar 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://stanfordhealthcare.org/doctors/s/aruna-subramanian.html 
https://profiles.stanford.edu/yvonne-maldonado ","Stanford epidemiologists are conducting a clinical trial to see if the antiviral drug favipiravir prevents SARS-CoV-2 from replicating in human cells, halts the shedding of the virus and reduces the severity of infection in people with mild or asymptomatic COVID-19. They plan to enroll 120 people who have been recently diagnosed with COVID-19 and are not in the hospital. Participants will receive either favipiravir, which is used to treat influenza in Japan, or a placebo."
Evaluating the potency and durability of slow-delivery SARS-CoV-2 vaccines via a hydrogel,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/lingyin-li 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/eric-appel 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== ","The Appel lab is exploring vaccination strategies that make use of a hydrogel that allows sustained, controlled release of small molecules over a period of weeks. In studies in mice, they are testing the ability of this gel, developed in the Appel lab, to slowly release experimental vaccines against SARS-CoV-2 as well as cGAMP molecules, which research has shown can boost a vaccine’s potency. The study will also assess the potency of the vaccines when delivered in this way."
Clinical trial of remdesivir in hospitalized adults with COVID-19,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/neera-ahuja 
https://med.stanford.edu/profiles/neera-ahuja 
https://med.stanford.edu/profiles/kari-nadeau 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/kari-nadeau ","Nadeau and Ahuja are conducting a randomized, double-blind, placebo-controlled phase 2 trial to evaluate the safety and efficacy of the Ebola drug remdesivir in hospitalized adult patients diagnosed with COVID-19. The study is sponsored by the National Institutes of Health and is a multicenter trial that will be conducted at as many as 50 sites globally."
Clinical trial of novel therapeutic for mild COVID-19 infection to prevent severe disease and reduce viral shedding,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/upinder-singh 
https://profiles.stanford.edu/jason-andrews 
https://med.stanford.edu/profiles/jason-andrews 
https://med.stanford.edu/profiles/prasanna-jagannathan 
https://surf.stanford.edu/covid-19-tools/covid-19/ 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://abslab.sites.stanford.edu/ 
https://profiles.stanford.edu/julie-parsonnet 
https://med.stanford.edu/profiles/julie-parsonnet ","Singh’s team is conducting a trial of a novel therapeutic called Lambda, a broad-spectrum anti-viral compound that’s been given to more than 3,000 patients in clinical trials of hepatitis viruses, for efficacy in outpatients with mild COVID-19. In vitro and animal-model data suggest Lambda may also inhibit replication of respiratory viruses, such as the COVID-19 virus. The team plans to perform a phase 2 randomized controlled trial of Lambda among outpatients with mild COVID-19 to determine whether the drug reduces the duration of symptoms, viral shedding and the risk of hospitalization."
Develop proofs-of-concept for two novel COVID-19 drugs to begin clinical trials,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/jeffrey-glenn 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/rhiju-das ","Glenn is preparing two potential COVID-19 drugs for clinical trials: a lipid kinase inhibitor that could be used to combat COVID-19 and other viruses, and a locked nucleic acid, similar to one that he has successfully developed to target every known strain of the flu and that could potentially be used during any flu pandemic. Both of these drugs could treat multiple viruses and strains, have high barriers to resistance, and, in some cases, could be used in nonviral applications."
Using artificial intelligence to predict drugs that may inhibit COVID-19,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://surf.stanford.edu/covid-19-tools/covid-19/ 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://abslab.sites.stanford.edu/ 
https://med.stanford.edu/profiles/russ-altman ","Altman and his group have used artificial intelligence to computationally predict six drugs that could inhibit TMPRSS2, a protein that plays a key role in SARS-CoV-2 infections. Altman and his collaborators outside of Stanford Medicine plan to conduct experimental follow-up studies to explore the efficacy of two of the drugs in blocking SARS-CoV-2 from causing infection. While promising, the potential drugs are still part of a preliminary computational analysis and would be dangerous to use clinically at this time."
Assessing COVID-19-related needs among low-income and racial and ethnic minority populations,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/lisa-goldman-rosas ","Goldman Rosas and team are assessing COVID-19-related needs among Bay Area low-income and racial and ethnic minority populations, using surveys and interviews to rapidly disseminate results to community partner organizations. The quantitative and qualitative data they collect will enable them to work with community partners to plan interventions that address disparities."
Genomic surveillance to identify silent transmission clusters of COVID-19,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/jason-andrews 
https://med.stanford.edu/profiles/jason-andrews 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== ",Andrews’ team is developing and testing novel tools that utilize microbial whole-genome sequences to identify chains of transmission between individuals. Andrews proposes to work with local hospitals and the state and county health departments to perform whole-genome sequencing on all COVID-19-positive samples and apply these methods in real-time to characterize transmission chains and help guide public health investigations.
Determining pathogenicity of various variants and strains of COVID-19,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/michael-snyder 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/benjamin-pinsky ","Snyder and his group plan to track different variants and strains of COVID-19 and quantitatively determine which ones correlate with different phenotypes, such as levels of pathogenicity. His team also plans to study the false negative rate of COVID-19, seeking to better understand how many people receive a false negative test result during early stages of the disease."
COVID-19 and Stanford WELL for Life study to understand the effects of shelter-in-place on well-being,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/ann-hsing 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== ","Hsing and the Stanford WELL for Life team are investigating the effect of COVID-19 and the shelter-in-place order on well-being. They are surveying existing Stanford WELL for Life participants (about 5,000) with the WELL questionnaire, which measures distress and multiple dimensions of well-being longitudinally at six time points over the next 12 months. This approach will enable the evaluation of the short- and long-term effects of COVID-19 quarantine and social distancing on emotions, social connectedness and physical health."
Investigation of possible oral-fecal transmission of SARS-CoV-2 in the Bay Area,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/niaz-banaei 
https://med.stanford.edu/profiles/niaz-banaei 
https://med.stanford.edu/profiles/angela-rogers 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/ami-bhatt 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/benjamin-pinsky 
https://med.stanford.edu/profiles/arezvani ","The Bhatt group and collaborators are investigating whether SARS-CoV-2 was circulating through oral-fecal cycles in the Bay Area community. The lab plans to screen stool samples collected through a biobank at Stanford for signs of SARS-CoV-2 from December 2019 through December 2020. Depending on sample availability, the team also plans to research whether a patient’s gut microbiome composition affects gastrointestinal symptoms of COVID-19, as well as other details about how the virus sheds."
Enhancing the public health data ecosystem for COVID-19 prevention,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/lorene-nelson 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/lorene-nelson ","Nelson and her team are building an integrated geospatial data ecosystem for examining geographic clustering and unequal burden of COVID-19 by income, race/ethnicity, household crowding and other social determinants of health. They will begin with Santa Clara and Solano counties, but the system is scalable to all 58 California counties. This work will enable public health agencies to identify risk factors for SARS-CoV-2 infection and predict and prevent future outbreaks. "
Model for hospital bed and resource use projections,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/david-scheinker 
https://med.stanford.edu/profiles/david-scheinker 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== ","Scheinker’s team has developed two interactive models that are available online to the public. One helps project bed and resource capacity, and the other helps  project the number of hospitalizations countywide."
Modeling outcomes of COVID-19 patients,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/tina-hernandez-boussard 
https://profiles.stanford.edu/manisha-desai 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== ","Hernandez-Boussard and Desai plan to use data from patients who tested positive for COVID-19 at Stanford Health Care to investigate how disease burden varies significantly in patients infected with the virus. Currently, the association of co-infections, symptomatology, comorbidities and other parameters on patient trajectories is unknown."
"School closures, health care worker absenteeism, and child care subsidies",Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/elizabeth-chin 
https://profiles.stanford.edu/benjamin-huynh 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== ","School closures help reduce peak hospital bed demand, but they can unintentionally cause health care worker absenteeism for those with children. Huynh and Chin are examining the economic feasibility of child care subsidies, as well as the policy effects of child care interventions on absenteeism at Stanford Health Care."
COVID-19 patients presenting in impending respiratory failure from ambulatory settings,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/steven-asch 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/harris-carmichael ",Carmichael and Asch are investigating the connection between unusual symptoms of COVID-19 and the frequency that those cases become ambulatory patients with severe respiratory failure or impending severe respiratory failure. Their objective is to describe clinical factors that may identify people with COVID-19 predisposed to severe respiratory failure outside the hospital.
Systems biological “multi-omics” analysis of immunity to COVID-19 infection,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/bali-pulendran ",Pulendran is investigating the interaction between the human immune system and the SARS-CoV-2 virus through systems-biological methods. His group will use a “multi-omics” approach to probe the host immune system response to SARS-CoV-2 during asymptomatic and symptomatic phases of infection. Their goal is to determine why some people get more severe symptoms than others and to identify biomarkers that predict disease severity in vulnerable populations. His group will also study the immune mechanisms by which vaccines confer protection against SARS-CoV-2.
Deep omics profiling to determine the genomic factors at play in disease severity,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/victoria-parikh 
https://profiles.stanford.edu/matthew-wheeler 
https://profiles.stanford.edu/manuel-rivas 
https://profiles.stanford.edu/euan-ashley 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/carlos-bustamante ","Ashley, Parikh and their team are sequencing genomic information from SARS-CoV-2 and human hosts to better understand the diversity of host responses to the virus. Their work aims to better elucidate genomic details underlying COVID-19 disease severity. To do so, the team will collect de-identified omic and clinical data for 1,000 Stanford patients who tested positive for COVID-19-, including hospitalized patients and patients who were in the intensive care unit."
Role of antibodies in SARS-CoV-2 infection and COVID-19 disease ,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/taia-wang ","Wang and her group are studying molecules that correlate with immunity against COVID-19. Their studies focus on defining a protective antibody response, and they will investigate whether antibodies have a role in determining the severity of COVID-19. The overarching goal of this work is to guide the development of vaccines and monoclonal antibody therapeutics against SARS-CoV-2."
Comparative pathology and pathogenesis of COVID-19 infections in humans and animal models,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://surf.stanford.edu/covid-19-tools/covid-19/ 
https://profiles.stanford.edu/sizun-jiang 
https://profiles.stanford.edu/brice-gaudilliere 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/garry-nolan 
https://abslab.sites.stanford.edu/ 
https://profiles.stanford.edu/david-mcilwain ",Nolan and his team are applying multiplexed technologies to achieve in-depth profiling of immune responses to SARS-CoV-2 in nonclinical and clinical studies. Their goal is to identify immune markers associated with outcomes for COVID-19 and understand the arrangement of immune cells relative to lung tissue cells during infection.
SARS-CoV-2 tissue specificity and its role in progression to multi-organ failure,Stanford," https://profiles.stanford.edu/scott-boyd 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== ","An increasing number of reports show the association of COVID-19 deaths with cardiac injury, cardiac arrest, arrhythmias and likely myocarditis. It is largely unclear if these serious and sometimes fatal conditions are due to direct SARS-CoV-2 influence, immunological responses or complications from existing cardiovascular disorders. Through this project, Boyd, Nielsen and their team aim to investigate which tissues support the growth of SARS-CoV-2. They will also analyze the local tissue B-cell-mediated immune responses in COVID-19 to assess for antibody responses contributing to tissue pathology."
The Apollo study,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/lorene-nelson 
https://med.stanford.edu/profiles/melissa-bondy 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/steven-goodman 
https://profiles.stanford.edu/lorene-nelson ","Bondy, Nelson and Goodman have launched a national survey that aims to assess how the COVID-19 pandemic is affecting the population physically, socially, emotionally and financially. The team’s survey is hosted by an app, called Apollo, that’s designed to screen patients at drive-through COVID-19 testing sites."
Caregiver survey COVID-19,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/ranak-trivedi ","Trivedi and her team are conducting an anonymous online survey to better understand the experiences of informal caregivers during the COVID-19 pandemic. Informal caregivers are family members or friends who provide significant help to people with mental or physical health conditions. Trivedi aims to use the results of the survey to guide advocacy efforts in support of informal caregivers. A link to the approximately 20-minute survey, which can be taken from anywhere in the world, is available at https://is.gd/stanfordcaregiverstudy."
Psychological stress associated with remote work during COVID-19 crisis,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/julian-martinez-rincon 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/angela-phillips 
https://profiles.stanford.edu/maheen-adamson ","Adamson and her lab are studying the global impact of psychological stress during the COVID-19 crisis. They are using an eight- to 10-minute survey to help evaluate individual stress levels caused by factors related to remote work, homeschooling and dependent care."
Impact of COVID-19 pandemic on sleep and mental health,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://med.stanford.edu/profiles/andrea-goldstein-piekarski ","Goldstein-Piekarski and the Computational Psychiatry and Neuroimaging Sleep Lab (CoPsyN Sleep Lab) are conducting a survey-based study examining the short- and long-term impacts of the COVID-19 pandemic and the shelter-in-place orders on sleep, mood and quality of life. The data collected in this study will also help identify factors that predict the development of chronic sleep problems and other negative mental health outcomes arising from stressful life events. "
Gastrointestinal manifestations in SARS-CoV-2,Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://profiles.stanford.edu/george-cholankeril 
https://med.stanford.edu/profiles/alexander-podboy 
https://profiles.stanford.edu/aijaz-ahmed 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== ","Cholankeril, Podboy and Ahmed aim to characterize the gastrointestinal symptoms associated with SARS-CoV-2 infection. Nearly one-third of patients in their study had gastrointestinal symptoms while infected with SARS-CoV-2. The team also saw mild elevations in liver enzymes in some patients, which may correlate with a need for a higher level of care. The group is continuing to investigate if gastrointestinal symptoms and liver enzyme abnormalities at presentation could be associated with increased severity of illness, requiring an escalation of care or higher rate of health care utilization."
"  The list isn’t comprehensive and instead represents a portion of Stanford Medicine research on COVID-19. If you are a Stanford Medicine scientist and would like to see your research included here, please send a note to: stanfordmed-communications@stanford.edu.",Stanford," http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTknHw-dA5wmrUMZzcPO-cDqwiX036YH0aCkH5r1TRDjRJrYe7KC1M-rW04oLwLekP_dUgqkJigmTmqCsidgzPSl71IfzTXzUCzU0_Or78aV4F6Sg6tVaUq-iXW4d8MAkiqEcRmJX_o-bOrZjaXbVIVM6-HzBhlSZDOhxfPvbmbMCZi5FFvZJSREoN3LBRb75HAT0VmeY-9HUo0bhqV-Z35yMSx2UUHYuTv2yE9MjQkgVk4GZ5yMQo3TvQiiBq45d4OSlxRVcr7lKdLBMfA2whlH7xpAZP3qy2dGpdj_ym3bv0kSdOCYwsfU9d2ZFUz2xw0nYZVSrq1M0vf_XTGJAFKy_0Ee7599I7-Mc99xREfBRlRjN_BL86lAlyU94eFJsYTqnMLZyovXW9Iq-VjWtF9CxPunCkXLIh-gmTbWuUiWUI2JWlYapupI6uBw0vpIxSNDOdHiKGxFKD7QK_zlBBgHpuqKEXQtui88c2FeL75Z-BnEkhDBnWQl0N2Y6ZnvHffOQc03Hl2kIMDJuRssmNSVFF-HxQmQl_7tB2zr6GcZzMB1l9C5qyCTg==&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://surf.stanford.edu/covid-19-tools/covid-19/ 
https://hai.stanford.edu/research/covid-19-collaboration-opportunities 
https://hai.stanford.edu/covid-19-collaboration-clearinghouse 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkzDQxa9c81KmQSRGkXB7kBqNtxrwdzsEdYK_BoplCLKCLf4bcBTh_j11h1U_22dDTIZwypCtGsdaCGDSwzbZ9dVNFOu720TxFISlk6u5ap1lspEg576JufFdurquzCxleoP5PWRKTJIcoPZ6aLjck8fk9Si_K3JRcAM_UFfTFAyL6hXhdw5o5NSSvhdUJoz2cS3HoNzf2h8lLz9qmY_R7TuG-JoiPe6RFJS2eUqTi5s-PfbwckDP2-QL-4fEUd8EnUWEENY_CCWhPJeFbrFoTVxeGhhytWAY1214nS2S-tiFhs5l3FriVnRnRAOelhmnA8abpj1jrCIpodSpGZodLcsRUOtCpmCBwaUFY6CR96XS6KNDMA7i_PlCdlOztUqQmgBVx5-h0AFSMve9ygZ3NPQcXsnG6wybR-aLaoUjezYXjEAHnB5Ryz91hG-kbGM_GmLbpsWoqXh5zunJT_RwGur5fsOMNloZZhcQ_tzJ_C_nQGFhFqOFY50vAvknXco4IcnQlvOcnv-g=&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
http://r20.rs6.net/tn.jsp?f=00151XeIMAu44HQXFv2TUqV1IuQo5SlCjtnHW6oetWociW9T4JguM9lAD5Td20tiJTkhW01PoNgGIFSmD8kQ69kQz71RPLXCmbl-EfaMV6-vmrFXRH86nS4dJXaE-PtDYe4-fVdRDfpdJVo2Twd7FMDmDyRFfN1uvvZiDob2TRIJjM03NO6rKcSiRqjhu-fbB5cuM_bhTx_tkyWUMOw2cwjXM83reN3OSaR7CrnW6Z51FRj2K_BiYsngiFvYRy-P9_istM58vrHFOVSE5IBjcREkpkUklI5rmN4dylWKQPSDauJCAQnF1Wn_ESchadQSQ7GvjEBsNucpU1raTCRt6wWNyyIFZxNYYlHlzMVxY5CFTFLsCpc8mlAY_0aiR5GTXhP8mh9wz7A1h8XYQvoiUwjKKvW0kfVIp08LBr720gcqRr23anLRzOr4cB5JCn3eHu9rng4eVhQplP0ykIJr8n_t-GUSlO7FC8-jC6GryYTM1wJRhDetxY1178VI26WG3Eo8BM0B3IeCCa4TeoYZF6Lr0kGMAOQOmAljtKX4OVCODaL1Z6XaLEQ0-nxpEoEuxtl9dN4azMIXiYR7qaaUQ-jDspratMLS1Keap3XRpBlxX9WCt7-YZjS1_cnqKfSHlxA&c=tlj6BTQ6imvAOSt3TI2UQsuhMvDD6vealYFJTLS_RsDqz1xjqAoeXg==&ch=HWYAdok6Tvn4X4zUd57jfYuIabs2_wUK6xFKbhbzHbxaKL-EOpNxbg== 
https://abslab.sites.stanford.edu/ 
https://pcrt.stanford.edu/covid ",Support Stanford Medicine’s response to COVID-19 by making a gift.
SPONSOR,Virginia Tech,https://www.usaid.gov/coronavirus/funding-requests-unsolicited-proposals,"UNDEFINED

Partners may submit unsolicited proposals to COVID19_Concepts@usaid.gov."
Catherine (Kate) Calder,UT Austin,No links but here is the point of contact: calder@austin.utexas.edu,"Professor
Dr. Calder is generating systematic information on
differences in social distancing across social groups by
income, race/ethnicity and residential neighborhood. She
is also investigating why these differences exist. This
study, supported by the National Science Foundation
through a RAPID grant, will assist epidemiologists
modeling disease spread by providing realistic
assumptions regarding social distancing practices across
the population."
Can Cenik,UT Austin,No links but here is the point of contact: ccenik@austin.utexas.edu,"Assistant Professor
Dr. Cenik is an expert on translation control and has recently
developed a rapid assay that enables the measurement of
translation activity in a wide range of systems. His collaborator at
the University of Toronto, Prof. Fritz Roth, has generated
expression constructs of viral genes (NSP1, NSP2 and N) derived
from SARS-CoV-2 isolate Wuhan-Hu-1. Dr. Cenik will leverage these
resources along with his novel standardized assay for assessing
translation activity of host cells in presence of viral proteins. This
study may help to better understand the mechanism of
pathogenicity of SARS- CoV-2 virus, in particular, and will help
evaluate proposed drug targets for SARS-CoV2."
Zhengrong Cui,UT Austin,No links but here is the point of contact: zhengrong.cui@austin.utexas.edu,"Professor
Dr. Cui will use his proprietary technology to develop
aerosolizable dry powder of i) a plasmid from a
sponsor showing activity against SARS-CoV-2 and ii)
two small molecules that are known to interrupt RNA
virus replication for potential prevention or treatment
of COVID-19."
Kevin Dalby,UT Austin,No links but here is the point of contact: dalby@austin.utexas.edu,"Dr. Dalby recently developed a lead therapeutic (and several
Professor
derivatives) and screened it against the whole protein kinome. He
found that it targets three protein kinases (AAK1, Abl, and JAK) with
high selectivity and sub-nanomolar potency. The compound is a
derivative of the FDA-approved drug Nintedanib. Through his
studies, UT Austin holds a patent on this compound and derivatives.
He is currently investigating its activity in a range of mammalian cells
to further validate its potency towards the three kinases. In several
weeks, he will be in a position to assess the ability of this inhibitor
and derivatives on host cell entry by COVID-19 using replication-
defective VSV particles bearing coronavirus S proteins (Hoffmann, M.
et al.). He has approximately 0.5 g of material already made to beginpre-clinical in vivo studies."
Jaquelin Dudley,UT Austin,No links but here is the point of contact: jdudley@austin.utexas.edu,"Professor
Dr. Dudley has been studying viruses, primarily retroviruses, since
1973. She has been teaching about animal viruses since 1983, has
served on NIH review panels on the pathogenesis of viruses, and is
the Associate Director of the LaMontagne Center for Infectious
Disease. Drs. Dudley and Shelley Payne are co-PIs on a grant to
identify Zika virus in biological samples. This project will be expanded
to include coronavirus detection, since the methods will be the
same. They will obtain inactivated coronovirus from the American
Type Culture Collection (ATCC), and it will be added to control
samples of blood, feces and urine to determine the sensitivity of
detection.  "
Livia Eberlin,UT Austin,No links but here is the point of contact: liviase@utexas.edu,"Assistant Professor
Dr. Eberlin is refining design of the MasSpec Pen (invented by
Eberlin) as a probe that could be inserted into the nose or throat for
immediate analysis/diagnosis of COVID-19. She has been discussing
with collaborators at the Texas Medical Center in Houston (oncology
MDs who are now assisting with COVID-19 efforts) how they could
potentially use the MasSpec Pen technology to rapidly identify
coronavirus directly from nasal or throat swab samples based on the
detection of small molecules that are highly specific to the virus with
mass spectrometry, in a similar fashion to experiments that Dr.
Eberlin pursues with bacteria in her lab."
Ilya Finkelstein,UT Austin,No links but here is the point of contact: ifinkelstein@cm.utexas.edu,"Associate Professor Dr. Finkelstein's immediate objective is to ramp up
mammalian and P. pastoris cell expression and biochemical
purification of the COVID-19 spike protein and receptor-
binding domain (RBD). He will be cloning, expressing, and
testing 60+ variants for improved yield and biophysical
stability. Spike protein and RBD truncations will be shipped
to academic and commercial labs for immediate serological
assay development. All efforts are in collaboration with Dr.
Jason McLellan’s lab. Dr. Finkelstein will be helping the
McLellan lab screen mAb-spike protein co-structures vianegative stain- and cryo-EM."
George Georgiou,UT Austin,No links but here is the point of contact: gg@che.utexas.edu,"Professor
Dr. Georgiou and his group will determine the adaptive
immune responses -- e.g., circulating antibodies, B cells and T
cells -- in convalescent patients using technologies developed by
our labs at UT Austin. This work will seek to define the antibody
and cellular immune responses elicited by SARS-CoV 2 and how
they may affect disease progression. These studies capitalize on
technologies invented by his group and are expected to provide
unique insights into immunological responses to infection.
Importantly, the work will also help the identification of
protective antibodies to SARS-CoV-2."
Debadyuti (Rana) Ghosh,UT Austin,No links but here is the point of contact: dghosh@austin.utexas.edu,"Assistant Professor Dr. Ghosh is collaborating with Dr. Manish Kumar and his lab in
Environmental Engineering to evaluate the ability of surfaces
molecularly functionalized with a plant derived antimicrobial
peptide to stop transmission of 2019-nCoV (i.e. the coronavirus
associated with COVID-19) using their T7 bacteriophages as model
systems that display the spike protein of 2019-nCoV. His
recombinant phages will serve as surrogates to test the efficacy of
these functionalized surfaces. He is at the initial phase of the work
to test his non-recombinant phages against functionalized surfaces;
this work will take 6-12 months. He is a Co-PI on an NSF RAPIDgrant supporting this work along with Dr. Kumar."
Jimmy Gollihar,UT Austin,No links but here is the point of contact: Essential,"Research Scientist
Dr. Gollihar is the DoD’s Chief Technology Officer of the
Bioindustrial Manufacturing Innovation Institute. He also serves
as the Biological Foundry and Synthetic Biology Lead at the U.S.
Army Research Laboratory--South where he works on
developing automated, high-throughput organism engineering
and biological countermeasure platforms. His research focuses
on the intersection of synthetic, systems, and computational
biology. He is also the molecular tools lead of the TRANSFORMEResearch Program at  the U.S. Army Combatj i m m y . d . g o l l i h a r 2 . c i v @ m a i l . m i l   C a p a b i l i t i e s   D e v e l o p m e n t   C o m m a n d   A r m y   R e s e a r c h   L a b o r a t o r y ."
Matthew Hall,UT Austin,No links but here is the point of contact: mjhall@mail.utexas.edu,"Professor Dr. Hall is working with the Austin Fire Department to apply ozone
sterilization to PPE masks (along with Drs. Chris Rylander and Nichole
Rylander). Dr. Hall will perform measurements of pressure drop across the
mask before and following ozone sterilization to determine mask intergrity
and safety for reuse. We have a plan to check the masks for changes in
pressure drop with use, as an indication of degradation of the filtering
media. The three PIs have also initiated a new research collaboration to
use a novel diesel engine approach for sterilization of indoor air containing
aerosolized pathogens including COVID-19. This approach will employ a
readily available system to impose high temperatures for short durations
to incinerate COVID-19 thereby inactivating the virus-laden air and
preventing disease spread."
Jon Huibregtse,UT Austin,No links but here is the point of contact: huibregtse@austin.utexas.edu,"Professor Dr. Huibregtse submitted a manuscript to Molecular Cell, showing that the SARS-CoV-
2/COVID-19 virus encodes a protease that counteracts the activity of the cellular
ISG15 anti-viral protein. This result establishes the viral protease (PLpro) as a drug
target for antiviral therapy. Further, the Mol. Cell paper proposes that a consequence
of PLpro de-ISGylase activity is the stimulation of a pro-inflammatory ""cytokine storm"".
COVID-19 patients die largely as a result of cytokine storms, and his results suggest a
clear route toward inhibiting the cytokine storm that is initiated as a result of PLpro
activity. Further, following submission of the Mol. Cell paper, he identified an FDA-
approved drug that inhibits the SARS-CoV-2 PLpro protease. The molecule blocks its
ability to act on ISG15 conjugates and we have strong preliminary evidence that this
will also block pro-inflammatory cytokine responses. This is a key finding, as it
suggests that the off-label use of an approved drug may directly impact patients
during the current crisis, if deployed rapidly."
Tanya Hutter,UT Austin,No links but here is the point of contact: tanya.hutter@utexas.edu,"Assistant Professor Dr. Hutter is working with Dr. Sapun Parekh to develop a rapid method of
SARS-CoV-2 detection in saliva combining a nanoporous material and simple
optical (reflectivity) measurement. Rapid and accurate detection of SARS-CoV-
2, the pathogen that causes COVID-19, is crucial in controlling the outbreak
within the community and in hospitals and is still a major bottleneck in nearly
every city in the US. The use of saliva has several important advantages; it is
easily accessible, will allow testing without the need for a medical provider,
and will permit specimen collection outside the hospitals such as in outpatient
clinics or in the community. Moreover, detection of the pathogen in
wastewater is attractive for similar reasons. Monitoring wastewater can help
fill in the gap of measuring how prevalent the virus is in a given community –
data that is useful in modeling the pandemic propagation and futureo u t b r e a k s ."
Gregory Ippolito,UT Austin,No links but here is the point of contact: gci@utexas.edu,"Research Assistant Professor
Dr. Ippolito in collaboration with Drs. Jason Lavinder, Jason McLellan,
Jimmy Gollihar and George Georgiou have begun antibody
experiments on COVID-19+(positive) blood specimens and now have
preliminary data. This project launched March 21, 2020, and has
enrolled and collected blood specimens from confirmed COVID-19+
ATX study subjects that experienced mild disease, as of March 30th
(study approved for up to N=20). His team is recruiting asymptomatic
patients and also patients with clinically severe disease. The work is
collaborative and includes the CDC, Albert Einstein College of Medicine,
and Houston Methodist Hospital."
Brent Iverson,UT Austin,No links but here is the point of contact: iversonb@austin.utexas.edu,"Dr. Iverson will be using his patented YESS technology to carry out the first
Professor
complete substrate profile of the main protease of SARS-CoV-2 and to carry out a
similar analysis of the human protease (TMPRSS2) responsible for priming the
SARS-CoV-2 S protein during the initial phases of infection. The goal would be to
identify a highly active specific substrate that could aid in rational drug design or
high throughput drug screening (inhibiting this protease would effectively treat
COVID-19). He hopes to develop a highly sensitive substrate that could be used as
a rapid diagnostic. In an attempt to produce a catalytic therapeutic, Dr. Iverson will
use his YESS technology to engineer a human protease that can cleave the
recognition sequence of the SARS-CoV-2 spike protein. YESS is the most effective
protease engineering platform known. He believes that a human protease
engineered to specifically cleave the recognition sequence of the SARS-CoV-2 spikeprotein would be able to stop the spread of the virus in a patient in immediate andc a t a l y t i c   f a s h i o n ."
Ning (Jenny) Jiang,UT Austin,No links but here is the point of contact: jiang@austin.utexas.edu,"Associate Professor
Dr. Jiang is interested in two aims: Aim 1 is to assess the antigenic epitope
coverage of SARS-COV-2, the virus causing COVID-19, in
healthy blood donors’ T cells (blood samples used are previously banked
before March 13th); Aim 2 is to identify antigen-specific B cells that bind
specifically to SARS-COV-2 proteins but no other cold inducing coronavirus,
which could be developed into antibody based therapeutics."
Ken Johnson,UT Austin,No links but here is the point of contact: kajohnson@mail.utexas.edu,"Dr. Johnson's research is focused on the examination of DNA and RNA
Professor
polymerases involved in the treatment of viral infections, and mechanisms
for force production by molecular motors. He started work on the SARS-
Cov2 coronavirus RdRp (RNA dependent RNA polymerase). He also has the
world's supply of sofosbuvir in its triphosphate form provided by Gilead.
This is the drug used to treat the related Hepatitis C by inhibiting its RdRp,
which is related to the coronavirus polymerase. He has a paper under
revision on why sofosbuvir is effective in treating HCV, while other similar
nucleoside analogs fail. He expects that he can quickly determine the same
information for SARS-Cov2 and to test other analogs that may be available
for treatment. His enzyme assays are well established in his lab. These
assays provide much faster turnaround to determine possible effectivenessof drugs to inhibit coronavirus replication."
Michael Krische,UT Austin,No links but here is the point of contact: mkrische@cm.utexas.edu,"Professor
Dr. Krische and his research team specializes in the synthesis of
polyketide natural products, and their ongoing research into the
development of catalytic C-C bond forming reactions should provide
us with the capability of preparing useful quantities of mycalamide so
that its therapeutic potential vis-à-vis COVID-19 can be evaluated. The
polyketide natural product, mycalamide, which was isolated from a
marine sponge of the coast of New Zealand, displays potent anti-
COVID-19 activity in mouse models. Remarkably, mycalamide is active
at a concentration of 1–2ng/disc. The natural abundance of
mycalamide is exceptionally/vanishingly low and there is nocommercial source."
Manish Kumar,UT Austin,No links but here is the point of contact: manish.kumar@utexas.edu,"Associate Professor Dr. Kumar aims to develop a rapid method to create simple barrier
materials to prevent transmission of the virus responsible for COVID-19.
He is working on generating and testing surrogates of the 2019-nCoV virus
(responsible for the COVID-19 disease) to test for removal using various
techniques. He is trying to develop a rapid method to coat masks and
HVAC filters with an antimicrobial peptide solution that has shown in
simulation studies to selectively immobilize the exposed spike protein of
the virus. He is working in collaboration with Dr. Jason McLellan who
recently published the atomic structure of this spike protein and with Dr.
Debadyuti Ghosh. They are also collaborating with Dr. Navid Saleh on his
COVID-19 work to create nanomaterials that can be used to inactivate the
virus. Dr. Kumar has received NSF RAPID funding to pursue his work withDr. Ghosh."
Jason Lavinder,UT Austin,No links but here is the point of contact: jlavinder@utexas.edu,"Research Associate
Dr. Lavinder works in the Georgiou/Ippolito laboratory as the
primary scientific lead and Co-I/Co-PI on antibody repertoire
related research, primarily focusing on the human adaptive
immune response to infectious disease."
Min Kyung Lee,UT Austin,No links but here is the point of contact: minkyung.lee@austin.utexas.edu,"Assistant Professor
Dr. Lee's background is in human-computer interaction and
human-centered AI. She is interested in investigating how to
leverage social computing and AI to promote healthy
information behaviors, and reduce negative social stereotypes
and inaccurate information. She is a Co-PI with Dr. Ken
Fleischmann on a recently funded NSF RAPID grant that
examines trust in public health information during the COVID-
19 pandemic."
Mo Maniruzzaman,UT Austin,No links but here is the point of contact: m.maniruzzaman@austin.utexas.edu,"Assistant Professor
Dr. Maniruzzaman focuses on pharmaceutical process 
engineering, continuous manufacturing and 3D printing of
medicines. Additional projects focus on 3D bioprinting of
scaffolds and smart medical implants as well as ultra-portable
drug delivery devices. Dr. Maniruzzaman is currently working
with the City of Austin to 3D-print COVID-19 nasal swabs."
Edward Marcotte,UT Austin,No links but here is the point of contact: marcotte@icmb.utexas.edu,"Professor Dr. Marcotte is surveying available instruments and reagents on
campus in case there is a need to support local official COVID-19
RT-qPCR testing with university resources. Should it prove
necessary, he will collect and distribute the resources, which
include analytical instruments (RT-qPCR machines), portable
biological safety cabinets, and reagents. He is also working to
implement an alternative, higher-throughput (3K tests/day, possibly
scalable to 10K) COVID-19 testing protocol that leverages the DNA
sequencing instruments in the Genome Sequencing and Analysis
Facility (GSAF). For this project, his group is primarily providing off-
site bioinformatics support."
Stephen Martin,UT Austin,No links but here is the point of contact: sfmartin@mail.utexas.edu,"Professor Dr. Martin's research is focused primarily in synthetic and bioorganic
chemistry, and in chemical biology. He has been working for the past
several years developing compounds that selectively target the
Sigma 1 receptor and TMEM97 as potential therapeutic agents to
treat neurological diseases and conditions. New compounds having
improved selectivity profiles that also have better drug-like
properties are needed. A recently published paper showed that
both the sigma 1 receptor and TMEM97 are potential drug targets
for developing drugs to treat COVID-19. He will also need to
resynthesize several compounds he has already identified as
selective sigma 1 receptor and TMEM97 binders for testing."
Jennifer Maynard,UT Austin,No links but here is the point of contact: maynard@che.utexas.edu,"Professor Dr. Maynard is pursuing three complementary approaches for
rapid discovery of antibodies that could be used in COVID-19
diagnostic point-of-care tests: She is experimentally selecting
beta-coronavirus cross-reactive antibodies from MERS-
immunized mice. She is also rationally re-engineering
previously described antibodies that bind SARS COV-1 with
high affinity for COVID-19 binding. Finally, she is rapidly
cloning, expressing and screening large numbers of COVID-19
spike variants for use by structural biology labs worldwide, as
they work to predict which mutations are likely to increasevirus expression."
Lauren Meyers,UT Austin,No links but here is the point of contact: utexas.edu,"Professor Dr. Meyers' research focus includes network epidemiology, optimization of
infectious disease surveillance and control, and translational tools for public
health. Her work has included uncovering the sociological and biological drivers
of influenza transmission, improving disease control policies for influenza and
HIV, redesigning disease surveillance systems to harness next-generation data,
and creating decision-support software for the Centers for Disease Control and
Prevention (CDC), Association of Public Health Labs (APHL), Defense Threat
Reduction Agency (DTRA) and Texas Department of State Health Services
(DSHS). She is currently modeling how quickly the coronavirus can spread,
including asymptomatic transmission of the virus. 
 
Recent UT News Release: Coronavirus Spreads Quickly and Sometimes Before
laurenmeyers@austin.
People Have Symptoms, Study Finds"
Thomas Milner,UT Austin,No links but here is the point of contact: terra.laser@gmail.com,"Department of Electrical and Computer Engineering
Professor
Dr. Milner's research is directed toward the development of novel
optical tomographic imaging modalities and laser surgical
procedures for diagnosis and treatment of disease in humans. He
is currently working on three projects related to COVID-19: 1)
Verifying a low-cost rapidly prototyped ICU ventilator that could be
deployed locally should an ICU saturation occur, 2) airway laser
destruction of COVID-19 in the larynx, trachea and nasal airways,
and 3) using the laser to treat secondary negative problems when
a person who has cured of an acute severe viral infection develops
a severe chronic lung disease – lung fibrosis."
Pawel Misztal,UT Austin,No links but here is the point of contact: misztal@utexas.edu,"Assistant Professor
Dr. Misztal's Lab houses a Vocus2R mass spectrometer that
is being used in collaboration with Drs. Lea Hildebrandt Ruiz
and Atila Novaselac on COVID-19 work. He is a Co-PI on an
NSF RAPID grant supporting this work, along with Drs.
Hildebrandt Ruiz and Novaselac."
Sapun Parekh,UT Austin,No links but here is the point of contact: sparekh@utexas.edu,"Dr. Parekh tests the uptake potential of a viral mimic, using the 2019-nCoV
Assistant Professor
spike (S) glycoprotein, a crucial part of the protein corona enveloping the
virus. 2019-nCoV-S has been found to bind to the angiotensin-converting
enzyme (ACE2) receptor on cells leading to internalization analogous with
SARS-CoV-S, the spike protein of the SARS coronavirus that had its
outbreak in 2003. Dr. Parekh proposes the use of ACE-positive lung
epithelial cells that are known to take up the SARS-CoV-S and test the
uptake of S-protein coated microspheres. He wants to both quantify the
magnitude of uptake and to visualize the subcellular localization of the
protein. He is also proposing to help elucidate the infectious ability with
respect to two variables: ambient temperature and patient age to assist
with therapeutic development and link observed epidemiology with actualcellular infection."
Shelley Payne,UT Austin,No links but here is the point of contact: payne@utexas.edu,"Professor
Dr. Payne's research is focused on human infectious
diseases. Although her work focuses on bacterial pathogens,
she also has a project on Zika. Drs. Payne and Jaquelin
Dudley are co-PIs on a grant to identify Zika virus in biological
samples. This project will be expanded to include coronavirus
detection, since the methods will be the same. They will
obtain inactivated coronovirus from the American Type
Culture Collection (ATCC.  The inactivated virus will be added
to control samples of blood, feces and urine and the
sensitivity of detection determined. "
John Powers,UT Austin,No links but here is the point of contact: john.powers@austin.utexas.edu,"Assistant Professor
Dr. Powers focuses on understanding the underlying genetic
mechanisms leading to pediatric neuroblastoma. He will work
on a bacteriophage-based vaccine platform to develop a
vaccine against COVID-19. It was originally envisioned as a
personalized cancer vaccine, and he believes it would be
valuable as a pathogen vaccine system as well. It has the
advantages of exceptional speed to produce vaccine
candidates, ease and speed of scaling up, and low long term
cost."
Chris Rylander,UT Austin,No links but here is the point of contact: cgr@austin.utexas.edu,"Associate Professor Dr. Rylander is working with the Austin Fire Department to
apply ozone sterilization to PPE masks (along with Drs.
Matthew Hall and Nichole Rylander). Dr. Rylander will design
the experimental approach and build relevant equipment for
ozone exposure and assessment. The three PIs have also
initiated a new research collaboration to use a novel diesel
engine approach for sterilization of indoor air containing
aerosolized pathogens including COVID-19. This approach
will employ a readily available system to impose high
temperatures for short durations to incinerate COVID-19
thereby inactivating the virus-laden air and preventingdisease spread."
Nichole Rylander,UT Austin,No links but here is the point of contact: mnr@austin.utexas.edu,"Associate Professor Dr. Rylander is working with the Austin Fire Department to apply ozone
sterilization to PPE masks (along with  Drs. Chris Rylander and Matthew
Hall). Dr. Rylander will assess mask effectiveness for protection against
bacteria and viruses by measuring their inactivation following ozone
sterilization, and she will be in charge of culturing representative bacteria
and viruses for testing and determining appropriate parameters for
inactivation of COVID-19. The three PIs have also initiated a new research
collaboration to use a novel diesel engine approach for sterilization of
indoor air containing aerosolized pathogens including COVID-19. This
approach will employ a readily available system to impose high
temperatures for short durations to incinerate COVID-19 thereby
inactivating the virus-laden air and preventing disease spread. Her lab will
be the site for culture of bacteria/viruses and evaluation of theirinactivation by the engine."
Navid Saleh,UT Austin,No links but here is the point of contact: navid.saleh@utexas.edu,"Associate Professor
Dr. Saleh recently received funding from the NSF to modify
mask surfaces (both surgical and N95) to improve their
capture and inactivation of SARS-CoV-2. In this project, he will
be modifying surgical mask surfaces with surfactant-coated
carbon particles at different ratios and moisture content,
testing the efficacy of the modified mask surfaces to attach
and inactivate a range of viruses including SARS-CoV-2, and
working to understand the mechanisms of attachment and
inactivation."
Jonathan Sessler,UT Austin,No links but here is the point of contact: sessler@cm.utexas.edu,"Professor Dr. Sessler will re-prepare zinc transporters for shipping to the
University of Arizona for testing as potential corona virus
antivirals. Anecdotal evidence lends support to the hypothesis
that zinc may mitigate the severity of the illness. However, zinc
salts are poorly transported into cells. Dr. Sessler solved this
problem back in 2008 in the context of anticancer studies
published that year in Cancer Research. He will re-synthesize
those compounds. He will also carry out confirmatory cell tests
as needed to ensure no toxic impurities are present in the
shipment. He is looking for antiviral activity, not just random
killing. So, this is an important control."
Jason Shear,UT Austin,No links but here is the point of contact: jshear@mail.utexas.edu,"Professor
Dr. Shear is developing optical-sensing platforms for the rapid
detection of the COVID-19 virus in samples derived from
biological and environmental sources (e.g., nose swabs, surface
wipes) based on modulation of graphene quantum dot (GQD)
Raman scattering or fluorescence signals. Initial studies will be
conducted using non-pathogenic surrogate virus platforms.
Once feasibility is demonstrated for rapid, sensitive, and reliable
detection, coronavirus-specific studies will be undertaken
through collaborative studies undertaken with appropriate BSL-
3 (and BSL-2) laboratories."
Hugh Smyth,UT Austin,No links but here is the point of contact: hugh.smyth@austin.utexas.edu,"Professor
Dr. Smyth is developing inhaled therapies for the treatment and
prevention of COVID-19 airway disease utilizing repurposed FDA
approved drugs. These inhaled formulations and drug-device
combinations are being manufactured and tested in his lab, also
in collaboration with Dr. Robert O. Williams III. These
formulations will be tested in vitro and in vivo in a BSL-3 lab at a
non-UT collaborators institution."
Haris Vikalo,UT Austin,No links but here is the point of contact: hvikalo@ece.utexas.edu,"Professor
Dr. Vikalo received NSF RAPID funding to analyze genomic data,
provide accurate identification of transmission clusters, and enable
detection of critical nodes in a network of pathogen hosts while also
providing insight into pathogen-mutation processes that occur during
the spread of COVID-19. He will use the methods he develops to
identify transmission clusters to analyze publicly available COVID-19
datasets."
Janet Walkow,UT Austin,No links but here is the point of contact: jwalkow@austin.utexas.edu,"Executive Director and Chief Technology Officer, Drug Dynamics Institute
Dr. Walkow is developing a drug product containing clofazimine, a
previously approved drug that has been identified as a potential
therapeutic against COVID-19."
Robert O. (Bill) Williams III,UT Austin,No links but here is the point of contact: bill.williams@austin.utexas.edu,"Division Head - Molecular Pharmaceutics and Drug Delivery
Dr. Williams is actively working on two RNA-based vaccines and two small
molecule drugs (mycophenolic acid and nuclosamide) using the drug delivery platforms
for which he has IP coverage: thin-film freezing for delivering the vaccines/drugs to the
lungs via dry powder inhalation. He is collaborating with several biotech companies who
are filing for FDA fast track for COVID-19 related new therapies. He is collaborating with
Jay Peters at UT Health San Antonio and the VA Hospital on a grant for inhaled drug
delivery of the two small molecule drugs.  He is also collaborating with Prof. Jai Hyun Seo
in Korea, who will begin testing on all of his formulations for inhaled and oral delivery in
his SARS CoV, SARS CoV-2 and MERS CoV animal infection models. 
 
Dr. Williams is in the process of treating lung-injured, aged animals with a peptide (LTI-
03) that has been shown to reverse severe lung injury. This work is being done in
collaboration with LungTherapeutics, a local company that is planning to start testing
LTI-03 for treating virus-induced lung injury in a mouse model. The outcome of thecurrent experiment would provide important data and rational for the continuation ofr e s e a r c h   i n t o   L T I - 0 3   a s   a   p o t e n t i a l   C O V I D - 1 9   t h e r a p e u t i c ."
Bo Xie,UT Austin,No links but here is the point of contact: boxie@utexas.edu,"Professor Dr. Xie and collegues recently submitted an opinion paper* on global health
crises accepted for publication in JASIST, a top journal in information science.
A few years ago, Dr. Xie received an NSF grant to study clinicians' information
wants during the Ebola crisis, and published the findings. This time around,
she wants to move further, to see her research findings translate into
something that makes a real difference outside of academia. She is a Co-PI
with Dr. Ken Fleischmann on a recently funded NSF RAPID grant that
examines trust in public health information during the COVID-19 pandemic.
 
*Op-Ed 
Xie, B., He, D., Mercer, T., Wang, Y., Wu, D., Fleischmann, K. R., Zhang, Y., Yoder, L. H.,
Stephens, K. K., Mackert, M., Lee, M. K. (in press). Global health crises are also
information crises: a call to action. Journal of the Association for Information Scienceand Technology (JASIST)."
Alison Preston,UT Austin,No links but here is the point of contact: preston@austin.utexas.edu,"Interim Vice President for Research
Dr. Preston is the Interim Vice President for Research and the
Dr. A. Wilson Nolle and Sir Raghunath P. Mahendroo Professor
of Neuroscience at UT. She is the director of the university’s
Bioimaging Research Center. Dr. Preston studies the cognitive
neuroscience of memory, with a particular focus in how
memory develops in children and teens. She also chairs the
Research Working Group, as part of the Executive Committee
lead by President Gregory Fenves and Interim President
Designate Jay Hartzell, to safely reopen campus to faculty, staff,
and students in 2020 during the COVID-19 pandemic."
Elizabeth A. Vandewater,UT Austin,No links but here is the point of contact: elizvan@austin.utexas.edu,"Research Development Officer
Dr. Vandewater is a seasoned NIH investigator, and she has played a
major role in several successful NIH Center grant applications. She
supports basic and applied biomedical and health related proposals,
with a particular focus on large, complex, agency proposals (e.g.,
multiple PIs, cross-college, cross-institution, etc.), such as center grants,
training grants, and cooperative agreements."
"Eunjung ""EJ"" Lee-Furman",UT Austin,No links but here is the point of contact: RIG@austin.utexas.edu,"Senior Special Projects Coordinator
Ms. Lee-Furman is a Certified Research Administrator who provides
comprehensive support to Research Interest Groups (RIGs) spanning
nearly all colleges, schools and units. RIGs are self-governed, PI-driven
groupings of researchers who share a research vision or goal, and who
convene to exchange knowledge, methods and expertise in support of
that research goal."
